Back to Agendas
The Role of Innovation in Clinical Trial Advocacy: Developing and Executing Patient-Centered Strategies and Partnerships Throughout the Continuum
Session Chair(s)
Lisa Palladino-Kim, EDD, MS
Assistant Professor / Director of Capstone, Rutgers School of Health Professions Clin Research Mgmt, United States
Industry is embracing the importance of diversifying the clinical trial patient population in an increasingly challenging recruitment landscape. The pharmaceutical industry's involvement with patient groups has historically focused on one-way communications, typically offering short-term results. A combination of new media and strategic communications leads to richer community engagement and increased responses.
Learning Objective : Demonstrate the role of patient-centered strategies in overcoming challenges and identifying opportunities that impact a drug’s development; Describe the importance of strategic partnerships; Apply best practices learned from innovative educational campaigns; Discuss how to spring-board the voice of patients into the development of clinical trials.
Speaker(s)
Clinical Trial Advocacy: Developing and Executing Advocacy Strategies from Discovery Through Drug Development
Mary Murray, MBA, MS
Family Caregiver, Independent Consultant, United States
Patient Advocate Perspective
Andrea Stern Ferris, MBA
President and CEO, LUNGevity Foundation, United States
Activating Patients for Clinical Trials Through Meaningful Education and Advocacy
Kristin Voorhees, MA
Director, Patient Advocacy, Ultragenyx, United States
Have an account?